# Nabla Bio: Biotechnology, Cambridge, United States

> Nabla Bio: Nabla Bio is a biotechnology company founded in 2020 that focuses on developing selective and functional drugs for previously undruggable...

Source: https://millionrounds.com/startup/nabla-bio (Millionrounds; every figure on the page links to its filing or article)

United States · [Biotechnology startup](https://millionrounds.com/companies)

# Nabla Bio

Nabla Bio is a biotechnology company founded in 2020 that focuses on developing selective and functional drugs for previously undruggable targets, such as GPCRs, ion channels, and transporters.

Funding reported Last round: Series A

Biotechnology Cambridge, United States

Company summary

- **Founded:** 2020 6 years old
- **Team:** 25 11 to 50 people
- **Funding reported:** $37M in dollars
- **Last round:** Series A May 2024

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Nabla Bio has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About Nabla Bio

Nabla Bio is a biotechnology company founded in 2020 that focuses on developing selective and functional drugs for previously undruggable targets, such as GPCRs, ion channels, and transporters.

The company utilizes artificial intelligence and wet-lab technologies, with its core offering being the AbMapTM Platform, also known as the JAM platform. This platform employs a multimodal generative modeling system to engineer antibodies and protein therapeutics with high precision. Nabla Bio operates on a B2B model, providing access to its platform through licensing agreements, partnerships, and collaborative projects. The company collaborates with leading pharmaceutical companies and biotech firms, including AstraZeneca, Bristol Myers Squibb, and Takeda, to enhance drug pipelines. Nabla Bio has secured significant funding, totaling $37 million, and is headquartered in Cambridge, Massachusetts. The team consists of experts in AI and protein design, and the company continues to grow by recruiting talent in machine learning and synthetic biology.

## What company datasets say Nabla Bio raised

Funding, as reported

Reported in all **$37M** in dollars

Rounds **5**

Last round **Series A**

Last round size **$26M**

Last round date **May 2024**

Investors listed **8**

Y Combinator **S20**

## Founders and team

From Nabla Bio's own website: 3 founders, 2 on the team.

**Frances Anastassacos** Co-founder & President

**Surge Biswas** Co-founder & CEO

**George Church** Co-founder

- **Rose Harrison** Chief Business Officer
- **Katie Warfel** Board of directors

## The company, in detail

What they build

Known for

membrane protein targeting health care target-specific antibody design multiplexed screening biologics development manufacturing de novo antibody design wet-lab technologies medical research ai protein design test-time scaling laws hospital & health care ai-driven drug design medical generative models target validation

Built with from their website

Docker PWA Flow Google Workspace Gem Viewport Meta webpack C3.js Amazon S3 Google Meet

+8 more

Priority Hints React ANGEL LMS Mobile Friendly Vercel Open Graph Radix UI Next.js

- **Sector:** Biotechnology
- **Industry code:** NAICS 541714, SIC 2834
- **Region:** Massachusetts
- **Revenue:** $4.7M a year, as listed
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/nabla-bio)

## Biotechnology in United States

Startups like it

- [**National Resilience** founded 2020 *Raised*](https://millionrounds.com/company/national-resilience)
- [**CREATE Medicines** Cambridge · founded 2019 *Raised*](https://millionrounds.com/company/create-medicines)
- [**AusperBio Therapeutics** Startup *Raised*](https://millionrounds.com/company/ausperbio-therapeutics)
- [**City Therapeutics** Startup *Raised*](https://millionrounds.com/company/city-therapeutics)
- [**Nohla Therapeutics** Seattle · founded 2015 *Raised*](https://millionrounds.com/company/nohla-therapeutics)
- [**Genapsys** Redwood City · founded 2010 *Raised*](https://millionrounds.com/company/genapsys)
- [**Proxima Bio** Startup *Raised*](https://millionrounds.com/company/proxima-bio)
- [**Infinimmune** Alameda · founded 2022 *Raised*](https://millionrounds.com/company/infinimmune)

## Is this your company?

Add your raise, your deck and your story, and put Nabla Bio in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)